S. 3133 · 116th Congress
Conditional Approval Act
- Stage
- In committee
- Sponsor
- Mike Braun
- Introduced
- 2019-12-19
- Latest action
- 2019-12-19 · Introduced in Senate
Summary
Conditional Approval Act
This bill authorizes the Food and Drug Administration to conditionally approve certain new drugs intended for diseases that are seriously debilitating, life threatening, or chronic, and for which meaningful treatments do not exist. The bill also limits liability related to these conditionally approved drugs.